In the News | Friends of Cancer Research

You are here

In the News

December 17, 2018
Executive Summary O’Brien assumes role from his late colleague and friend Dan Best as HHS closes out administrative items in the blueprint.   The Trump Administration appears to be ramping up towards... Read more
December 17, 2018
Executive Summary Abernethy comes to FDA from Flatiron Health, which develops oncology-specific electronic health record software and real-world evidence for cancer research. She succeeds FDA veteran... Read more
December 17, 2018
One of the leading voices in using health data to advance targeted treatments known as precision medicine has been tapped for the second-highest post at the FDA.   Amy Abernethy, chief medical... Read more
December 13, 2018
Executive Summary Record-setting pace of NME approvals is a cause for celebration. But is it a sign that drug industry R&D productivity has actually improved? The US FDA’s top drug review... Read more
December 11, 2018
Federal regulators put two experimental drugs targeting autism’s core symptoms on a fast track for testing and approval this year, but they’re still a long way from pharmacy shelves.   Balovaptan,... Read more
December 9, 2018
Executive Summary Amid concerns Office of New Drugs reorganization will result in sponsors receiving conflicting advice, new director offers several items already contemplated to prevent such... Read more
December 7, 2018
The National Cancer Institute (NCI) updated its clinical trial criteria to allow patients with specific health concerns to participate in NCI-funded clinical trials, as well as provide opportunities... Read more
December 4, 2018
The National Cancer Institute (NCI) has revised its clinical trial protocol template to expand eligibility criteria for cancer clinical trials. The updated criteria will allow patients with certain... Read more
December 3, 2018
The National Cancer Institute broadened the criteria for participation in NCI-funded clinical trials after meetings with cancer research organizations and the FDA. The new criteria expands... Read more
November 29, 2018
WASHINGTON, DC - The American Society of Clinical Oncology, Inc. (ASCO) and Friends of Cancer Research (Friends) applaud the National Cancer Institute's (NCI) recent revision of its clinical trial... Read more

Pages